Add an ACE Inhibitor or ARB to Her Current Carvedilol Regimen
For this 86-year-old woman on low-dose carvedilol who cannot tolerate HCTZ due to dizziness, the best next step is to add an ACE inhibitor (such as lisinopril 2.5-5 mg daily) or an ARB (such as losartan 25 mg daily) to her current beta-blocker therapy. This combination is guideline-recommended, evidence-based, and avoids the diuretic that causes her orthostatic symptoms 1.
Rationale for ACE Inhibitor or ARB Addition
The 2020 International Society of Hypertension guidelines explicitly recommend that for patients requiring additional blood pressure control beyond initial therapy, the next step should be adding a complementary first-line agent 1. Since she's already on a beta-blocker (carvedilol), adding an ACE inhibitor or ARB creates a rational, synergistic combination that addresses different pathophysiologic mechanisms of hypertension.
Key advantages of this approach:
- Avoids diuretics entirely, eliminating the orthostatic hypotension risk that caused her dizziness with HCTZ
- Proven cardiovascular benefit in elderly patients, particularly for stroke prevention 2
- Well-tolerated in the elderly when started at low doses and titrated carefully
- Complementary mechanism to her beta-blocker without redundancy
Specific Dosing Recommendations
Start with low doses given her age:
- Lisinopril 2.5-5 mg once daily, OR
- Losartan 25 mg once daily, OR
- Valsartan 20-40 mg once daily
These starting doses are specifically recommended for elderly patients and can be uptitrated gradually every 2-4 weeks based on blood pressure response and tolerability 3, 4. The FDA label for carvedilol notes that combination therapy with ACE inhibitors is standard practice and generally well-tolerated 5.
Alternative: Consider Uptitrating Carvedilol First
Before adding a second agent, consider increasing her carvedilol dose from 3.125 mg twice daily to 6.25 mg twice daily 5. She is currently on the absolute lowest starting dose, and the FDA-approved dosing for hypertension allows titration up to 25 mg twice daily 5. This approach:
- Maximizes her current single-agent therapy
- May provide adequate control without adding medications
- Is explicitly recommended in the carvedilol prescribing information for hypertension management 5
However, given her age and the "little better" control needed (suggesting she's not far from goal), adding rather than uptitrating may be more effective and reach target faster.
If ACE Inhibitor/ARB Not Tolerated: Calcium Channel Blocker
If she develops the classic ACE inhibitor cough (occurs in up to 10-20% of patients, more common in elderly women) or cannot tolerate an ARB, add a long-acting dihydropyridine calcium channel blocker such as amlodipine 2.5-5 mg daily 1.
Important caveat: Amlodipine can also cause peripheral edema and dizziness, particularly in the elderly, so start at 2.5 mg daily. The combination of beta-blocker plus calcium channel blocker is guideline-supported, though you should avoid non-dihydropyridine calcium channel blockers (diltiazem, verapamil) as they can cause excessive bradycardia when combined with beta-blockers 2, 6.
Blood Pressure Target for This Patient
Target BP should be individualized based on frailty status but generally <140/90 mmHg for elderly patients 1. The 2020 ISH guidelines specifically state to "individualize for elderly based on frailty" and suggest that 140/90 mmHg is appropriate for most elderly patients, with consideration for <130/80 mmHg in robust elderly patients 1. Given that she experienced dizziness with HCTZ, err on the side of a more conservative target (140/90 mmHg) to avoid orthostatic symptoms.
Critical Monitoring Points
Monitor closely for:
- Orthostatic vital signs at each visit—measure BP supine and after 1-3 minutes of standing, as elderly patients are at high risk for orthostatic hypotension with any BP medication changes
- Renal function and potassium within 1-2 weeks of starting ACE inhibitor/ARB, then periodically, as elderly patients are more susceptible to hyperkalemia and acute kidney injury 3, 7
- Symptomatic hypotension or dizziness, particularly in the first hour after dosing—the carvedilol label specifically warns about this 5
- Heart rate—carvedilol can cause bradycardia; if heart rate drops below 55 bpm, consider dose reduction 5
Why Not Other Options
Loop diuretics (furosemide): Less effective for hypertension control than thiazides and cause more electrolyte disturbances 2. Reserve for patients with heart failure or significant renal impairment.
Aldosterone antagonists (spironolactone): While effective, they carry significant hyperkalemia risk in elderly patients, particularly when combined with ACE inhibitors/ARBs 2, 7. Use only if resistant hypertension develops.
Alpha-blockers (doxazosin): Explicitly not recommended as first-line or second-line agents due to increased heart failure risk and orthostatic hypotension 2, 6. Given her dizziness with HCTZ, alpha-blockers would likely worsen orthostatic symptoms.